date:Dec 24, 2012
ained Yael Lifshitz, director, RD, Enzymotec Infant Nutrition.
Studying the effect of InFat on infant gut microbiota is innovative and further position InFat as the standard fat blend in premium infant formula, added Tzafra Cohen, CEO, Advanced Lipids. This new publication further strengthens InFats leading position in the market, with numerous benefits associated with its consumption.
InFat is a patented, clinically-proven fat blend (beta-palmitate structured lipids) for infant formula with